Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Lung Neoplasms 5Recurrence 4Neoplasm Metastasis 4Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, B-Cell 2Head and Neck Neoplasms 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Urinary Bladder Neoplasms 1Thyroid Diseases 1Smoking 1Prostatic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Oligodendroglioma 1Neuralgia 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Leukemia 1Laryngeal Diseases 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Gliosarcoma 1Glioblastoma 1Fallopian Tube Neoplasms 1

Interventions

Letrozole 4Anastrozole 3exemestane 2canakinumab 1Vitamin B 12 1Therapeutics 1Testosterone 1Tamoxifen 1Glucosamine 1Glucaric Acid 1Fatty Acids, Omega-3 1Chondroitin Sulfates 1Chondroitin 1Cholecalciferol 1Cannabidiol 1Calcium Gluconate 1Calcium Citrate 1Calcium Carbonate 1Calcium 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Arthralgia × Vitamin B 12 × Clear all
NCT03069313 2018-02-01

Vitamin B12 for Aromatase Inhibitors Musculoskeletal Symptoms

Texas Tech University Health Sciences Center, El Paso

Phase NA Completed
41 enrolled 8 charts
Breast

Breast Neoplasms, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡